Last reviewed · How we verify
NCT05802277: MECA_CYCLE
Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.
NA trial testing Hamstring muscles function assessment in Menstrual Cycle in 130 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | EZUS-LYON 1 |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 130 |
| Start date | 5 October 2022 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 April 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Hamstring muscles function assessment
Conditions studied
- Menstrual Cycle — all drugs for Menstrual Cycle →
- Oral Contraceptive Use — all drugs for Oral Contraceptive Use →
Sponsor
EZUS-LYON 1 — full company profile →
Who can join
Adults 18 to 35, female only, with Menstrual Cycle or Oral Contraceptive Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to precise the impact of menstrual cycle and physical activity on the hamstrings muscle function in healthy active women. The main question it aims to answer is : is there a moment of the menstrual cycle when the muscle is better able to recover from a strenuous exercise ? Three appointments will be conducted to evaluate the hamstring muscles at difference moments of the menstrual cycle. Echographic and maximal force production measures will be done. Researchers will compare these results with a group taking oral contraceptives.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05802277
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menstrual Cycle
Currently open trials in the same condition.
- NCT07248046 — Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study) · recruiting
- NCT07242209 — Sugammadex and Menstrual Cycle in Postoperative Nausea and Vomiting · recruiting
- NCT06771583 — Identification and Validation of Epigenetic Biomarkers of PMDD · recruiting
- NCT07258576 — Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise · NA · recruiting
- NCT06892080 — Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study · recruiting
Other EZUS-LYON 1 trials
Trials by the same sponsor.
- NCT05625828 — Evaluation of the Effects of a Cognitive-Motor Fall Prevention Program on Fall Risk Factors · NA · active not recruiting
- NCT02967965 — CARdioprotection in Myocardial Infarction · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05802277 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by EZUS-LYON 1
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05802277.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing